ICSI use in the U.S. with and without an insurance mandate: A report from the CDC
Date: Friday, June 8, 2018
This Journal Club Global will be streamed live from Midwest Reproductive Symposium International (MRSI 2018) to discuss "ICSI use in the US with and without an insurance mandate.
Dr. Ada C. Dieke, from Centers for Disease Control and Prevention, will discuss the recent Fertility and Sterility manuscript, "Intracytoplasmic Sperm Injection (ICSI) Use in States with and without Insurance Coverage Mandates for Infertility Treatment, United States, 2000-2015" with experts live at the symposium. Discussants will include Richard Paulson, M.D., Amber Cooper, M.D., M.S.C.I., and G. David Adamson, M.D.
Questions to be addressed include:
- Why has ICSI increased over the past 15 years in all states?
- Potential reasons ICSI has increase most dramatically in non–male factor infertility cycles.
- How has the practice of ICSI differs in states with an insurance coverage mandate?
- What are the advantages and disadvantage to ICSI for non-male factor cycles?
- Are the economic and biological incentives for ICSI balanced?
The Journal club will be hosted by Fertility and Sterility's Video and Media Editor, Kurt Barnhart, M.D., M.S.C.E. (University of Pennsylvania), and Angie Beltsos, M.D. (Executive Chairperson and Boardpresident of MRSi).